The soft-tissue robotic surgery market continues to expand.
Momentis Surgical has received FDA authorization for the ANOVO™ Surgical System, marking another important milestone in the arrival of new robotic platforms beyond the established players.
ANOVO is a robotic system featuring a novel articulated mechanism designed to provide high dexterity through a compact architecture. While it was designed for transvaginal surgery, it represents yet another example of the innovation currently reshaping the surgical robotics landscape.
As more systems enter clinical practice, understanding their design philosophy, technical solutions, and potential applications becomes increasingly important.
I have added ANOVO to headneckroboticsurgery.com, where you can find an overview of the platform, its technology, FDA authorization, and how it fits into the evolving ecosystem of soft-tissue surgical robots.
The number of robotic platforms continues to grow—and each one brings a different engineering approach to the operating room.
J Granell. Aug 2, 2026